Overview
Marrow Cellution™ is a closed-tip cannula system for bone-marrow aspirate concentrate (BMAC) harvest, manufactured by Aspire Medical Innovation in the United States. The defining engineering choice is the closed tip with side ports, which lets the cannula collect bone marrow from multiple geographies along a single puncture path within the iliac crest, rather than drawing from one fixed point at the tip as conventional open-tip cannulas do.
The clinical argument is twofold. First, a more representative cell yield: each side-port collection samples a different volume of trabecular marrow, which raises the concentration of stem and progenitor cells (CFU-f, the colony-forming unit-fibroblast assay used as the standard MSC-progenitor readout) relative to peripheral-blood dilution. Second, a simpler procedure: one puncture instead of multiple, and no centrifuge required - the system delivers concentrated marrow at the point of care without an off-bench processing step, capital equipment, or extra procedural time.
In Cyprus, BMAC sits in the private regenerative tier alongside Endoret® PRGF, Vivostat® PRF, and Tulip Nanofat™. Marrow Cellution™ is private-pay and not GESY-reimbursable; the General Healthcare System covers standard orthopaedic procedures only. OrganoGEN distributes Marrow Cellution™ to private clinics and hospitals across sports medicine, orthopaedics, and regenerative practice.
Indications & Contraindications
Indicated For
- Adjunct biologic in sports-medicine and orthopaedic procedures
- Soft-tissue and joint regenerative applications (tendinopathy, mild-to-moderate osteoarthritis, ligament and cartilage support)
- Combined biologic protocols with PRGF, Vivostat® PRF, or nanofat in advanced regenerative bundles
Contraindicated For
- Active local or systemic infection
- Active marrow malignancy
- Severe haematological disorders precluding marrow aspiration
- Patient with contraindication to marrow aspiration
Technical Specifications
| Manufacturer | Aspire Medical Innovation, USA |
|---|---|
| Distributor in Cyprus | OrganoGEN Limited |
| Indication | Bone-marrow aspirate concentrate (BMAC) harvest |
| Cannula design | Closed-tip with side ports, single-puncture harvest path |
| Sampling | Multiple geographies within the iliac crest along one puncture path |
| Output | High concentration of stem and progenitor cells (CFU-f) |
| Workflow | Point-of-care BMAC delivery, no centrifuge required |
| Regulatory | CE-marked under EU MDR 2017/745 |
| GESY status in Cyprus | Private-pay (regenerative medicine not GESY-reimbursable) |
GESY Coverage & Pricing in Cyprus
Marrow Cellution™ is not GESY-reimbursable in Cyprus. Regenerative medicine sits in the private-care tier, and BMAC procedures are delivered on a self-pay basis through private clinics and hospitals.
Contact OrganoGEN for surgeon and clinic referrals.
Frequently asked questions
Who manufactures Marrow Cellution™?
What is BMAC?
What makes the Marrow Cellution™ closed-tip cannula different?
Does Marrow Cellution™ need a centrifuge?
Is Marrow Cellution™ CE-marked?
Is Marrow Cellution™ covered by GESY?
How does Marrow Cellution™ fit into a regenerative-medicine plan?
More in Regenerative Medicine
Other products OrganoGEN distributes in the Regenerative Medicine category.
Endoret® PRGFPatient-derived Plasma Rich in Growth Factors (PRGF) for orthopaedics, sports medicine, oral surgery, and dermatology. Standardised BTI / Anitua protocol.
Vivostat® Fibrin / PRFFully automated on-site preparation of autologous fibrin sealant (PRF) from the patient's own blood. No donor material.
Tulip® NanofatClosed-system NanoSpin Pro™ processing for microfat and nanofat adipose-tissue grafting. Used in orthopaedics and aesthetic medicine.
